CAR-T cell therapy targeting CD19 (fully-human anti-CD19 CAR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T cell therapy targeting CD19 (fully-human anti-CD19 CAR), covering 2021-05-04 to 2021-05-04. Get the full timeline:
Most recent: Clinical Trial Update: T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies [Phase 1]